B7-H3 as a Target in Emerging Immunotherapy for Penile Cancer (HPV Vaccination in Males)
American Journal of Pathology & Research · 28.02.2026 · 5 (2)
DOI: 10.33425/2836-3647.1038 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pathology & Research, online erschienen am 28.02.2026. Verfasst von Graciela Ghirardi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Penile cancer is not common in developed countries, although it is common in some Latin American countries. It is related to cervical cancer. Therefore, it is important to promote vaccination in young men. Given the clinical/oncological management, there are new treatment proposals based on immunotherapy (IT), which favor organ preservation. Pathology reports must be increasingly strict regarding classification, IHC markers, and therapeutic strategies.
Objectives
To evaluate the perspective on the use of established HPV and IT markers to establish their relevance; to determine the specificity and sensitivity of the markers through IHC focused on the B7 H3 protein. Materials and methods: 27 penile cancer samples from patients in Paraguay underwent IHC at Bio SB, CA. USA, with 16 markers.
Results
The IHC markers HPV, B7H3, and HSP-27 were highly significant in the relationship between penile cancer and HPV. Based on our results, we recommend further investigation of the B7 homologous protein H3 and its potential as a target in immunotherapy and cancer.
Conclusion
Sample management should be performed by pathologists experienced in the pathogenesis, classification, and therapeutics of penile cancer. The function of B7-H3 as an immunoregulator and its practical use, the degree of involvement of agents and/or cofactors, and the local/systemic immune response remain to be elucidated, making it attractive and promising.
Zitieren
APA
Ghirardi, G., Murguia-Perez, M., & Agustin-Godinez, E. (2026). B7-H3 as a Target in Emerging Immunotherapy for Penile Cancer (HPV Vaccination in Males). American Journal of Pathology & Research, 5(2). https://doi.org/10.33425/2836-3647.1038
Vancouver
Ghirardi G, Murguia-Perez M, Agustin-Godinez E. B7-H3 as a Target in Emerging Immunotherapy for Penile Cancer (HPV Vaccination in Males). American Journal of Pathology & Research. 2026;5(2). doi:10.33425/2836-3647.1038
BibTeX
@article{Ghirardi2026,
author = {Ghirardi, Graciela and Murguia-Perez, Mario and Agustin-Godinez, Eduardo},
title = {B7-H3 as a Target in Emerging Immunotherapy for Penile Cancer (HPV Vaccination in Males)},
journal = {American Journal of Pathology & Research},
year = {2026},
volume = {5},
number = {2},
doi = {10.33425/2836-3647.1038}
}
EUVIMED